SO WHAT ARE SOME of the Potential Reasons for the escalating rise in PPS at $BDPT- toward its true market value ?
———————————————————
#1- CORPORATE GOVERNANCE AND DISCLOSURES:
THE decision by $BDPT management 4 years ago to start submiting AUDITED financials and all disclosures as a current SEC REGISTRANT was a direct example of management’s willingness to provide Full SEC Disclosure to its shareholders despite only being listed on the OTC markets exchange. This decision has enabled shareholders access to essential mandatory disclosures about management and new directors, patents and right to use, products for sale and other material events in a very timely manner. Imo- that has built shareholder faith that they will continue to communicate effectively with any material updates about their company.
Ex: This company issued 8 press releases in 1 month from 3/23 to 4/20 in 2023 to announce 2 new prestigious directors, 3 new license/marketing deals and a potential stock subsidiary spinoff.
2- THE MOVE FROM DEVELOPMENTAL STAGE company to one that’s Revenue Producing;
When analyzing a microcap’s chance at potential, it’s always easy to get lost in their UNFLATTERING Financials, derivatives and loans. It’s essential to the overall DD but equally important to put that debt feature in perspective. The key here is with products coming to market- and a brand new marketing and sales campaign in place for 2023 -$BDPT has moved to a different corporate stage.
What’s critical here is that PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. Their debts and obligations secured during the developmental stage have largely resulted in the current SS today and its necessity to maintain the 1.25bil AS. IMO- it was that satisfaction of debt that brought the cost down to a severely undervalued level.
FURTHER: for the OTC- 1.25Bil is still a very attractive AS and the OS currently listed around 420mil as of 5/31 - presents an opportunity for a continued accelerated rise from its current PPS.
